Awareness of Deficits in Dementia
Awareness of Deficits in Dementia
批准号:
7888075
负责人:
HOWARD J ROSEN
金额:
$29.52万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2015-05-31
关键词:
AccountingAgeAlzheimer&aposs DiseaseAwarenessBehaviorBrain imagingBrain regionCaregiversCerebrumCognitiveConsciousDataDementiaDiagnosticDiseaseEmotionalEmotionsEnsureEpisodic memoryEvaluationEventFailureFamilyFamily CaregiverFrontotemporal DementiaFunctional disorderGalvanic Skin ResponseGoalsHealthHeart RateHemispatial NeglectHippocampus (Brain)Home environmentIndividualInjuryJudgmentKnowledgeLeadLearningLifeMagnetic Resonance ImagingMeasuresMedialMemoryModelingMonitorMotivationNerve DegenerationNeurologicParahippocampal GyrusParietal LobeParticipantPatientsPerformancePhysiologic MonitoringPhysiologicalPlayProcessQuality of lifeQuestionnairesRecommendationRehabilitation therapyRelative (related person)ResistanceRisk BehaviorsRoleSafetySelf PerceptionSemanticsSocietiesStructureSupervisionSyndromeSystemTestingThinkingTimeTissuesUpdateWorkbasebehavior measurementbehavior testcompliance behaviordisabilityentorhinal cortexexecutive functionexpectationfallsgray matterneglectnervous system disorderneuromechanismpreventpublic health relevanceresponsestandard measure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a plan to study lack of awareness of one's disabiltities, called anosognosia, in patients with dementia. Anosognosia contributes to patients' disabilities and frustrates families and caregivers. Lack of awareness may prevent patients from adhering to treatment recommendations, and causes them to pursue potentially risky behaviors that are beyond their limits, requiring supervision to ensure their safety. Although anosognoia is very common in Alzheimer's disease, it is even more common in Frontotemporal dementia, and the reasons for this are not clear. We have developed a model attempting to explain how anosognosia could develop from failures of specific cognitive abilities, including monitoring one's performance and emotion, and we have devised a plan to test whether these factors contribute to anosognosia, and whether the contributing factors differ in patients with Alzheimer's disease and Frontotemporal dementia. We will study 100 healthy older individuals, 50 patients with Alzheimer's disease, and 50 patients with Frontotemporal dementia. We will pursue the following specific aims: A) To define the relative contributions of performance monitoring, other frontal/executive functions, memory, and emotional reactivity to anosognosia in AD and FTD. We hypothesize that: 1) In FTD, performance monitoring and physiological activation during cognitive tasks will be correlated with anosognosia even after accounting for the contributions of memory and executive functions. 2) In AD, but not FTD, memory for recent performance on cognitive testing will make a significant contribution to anosognosia.; We hypothesize that 1) tissue loss in the right medial orbitofrontal cortex will predict physiological activation during testing, behavioral estimates of performance monitoring, and overall level of self-awareness in both FTD and AD [after controlling for the contributions of other relevant brain regions. 2) tissue loss in medial temporal regions (hippocampus, entorhinal cortex, parahippocampal gyrus) will significantly predict overall level of self awareness in AD, after the effects of medial OFC are taken into account.] To examine the relationship between performance monitoring, physiological activation, and anosognosia: We hypothesize that physiological activation during cognitive testing will correlate with behavioral measures of performance-monitoring (post-error slowing [and decreased FOK]) and with overall level of self- awareness across diagnostic groups. If these hypotheses are confirmed, we will have a much clearer idea of why patients with dementia are not aware of their deficits.
PUBLIC HEALTH RELEVANCE: Patients with dementia are usually unaware, or marginally aware of their thinking problems and the effects these deficits have on their life. This project will attempt to understand why patients with dementia have such poor awareness of their disability using cognitive tests developed by neuroscientists, and using brain imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core F: Neuroimaging Core
-
批准号:10647912
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
Project 1
-
批准号:10228132
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
Core F: Neuroimaging Core
-
批准号:10431785
-
项目类别:
-
资助金额:$49.4万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
Project 1
-
批准号:10208708
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
Project 1
-
批准号:10450023
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
Project 1
-
批准号:9802933
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2019
-
负责人:HOWARD J ROSEN
-
依托单位:
PREDICT-ADFTD: Multimodal Imaging Prediction of AD/FTD and Differential Diagnosis
-
批准号:9240349
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2017
-
负责人:HOWARD J ROSEN
-
依托单位:
PREDICT-FTD: Multimodal Imaging Prediction of FTLD Subtypes.
-
批准号:10915129
-
项目类别:
-
资助金额:$140.83万
-
财政年份:2017
-
负责人:HOWARD J ROSEN
-
依托单位:
PREDICT-ADFTD: Multimodal Imaging Prediction of AD/FTD and Differential Diagnosis
-
批准号:10397226
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2017
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal Imaging in Frontotemporal Degeneration
-
批准号:10343692
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal imaging in frontotemporal degeneration
-
批准号:8724327
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal Imaging in Frontotemporal Degeneration
-
批准号:10555216
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Establishing Therapeutic Efficacy in Frontotemporal Degeneration
-
批准号:8652131
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal imaging in frontotemporal degeneration
-
批准号:8850370
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal imaging in frontotemporal degeneration
-
批准号:8567416
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Multimodal imaging in frontotemporal degeneration
-
批准号:9069717
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2013
-
负责人:HOWARD J ROSEN
-
依托单位:
Awareness of Deficits in Dementia
-
批准号:8079466
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2010
-
负责人:HOWARD J ROSEN
-
依托单位:
Awareness of Deficits in Dementia
-
批准号:8281580
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2010
-
负责人:HOWARD J ROSEN
-
依托单位:
Awareness of Deficits in Dementia
-
批准号:8484778
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2010
-
负责人:HOWARD J ROSEN
-
依托单位:
The Frontotemporal Lobar Degeneration Neuroimaging Initiative
-
批准号:8121405
-
项目类别:
-
资助金额:$203.41万
-
财政年份:2009
-
负责人:HOWARD J ROSEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: